CAS 1599432-08-2

Formule : C21H21BrN2O3

InChI : InChI=1S/C21H21BrN2O3/c1-27-19-9-5-17(6-10-19)21(26)24-14-12-23(13-15-24)20(25)11-4-16-2-7-18(22)8-3-16/h2-11H,12-15H2,1H3/b11-4+

Code InChI : OFHXXBRBGWUOHR-NYYWCZLTSA-N

SMILES : COC1=CC=C(C=C1)C(=O)N2CCN(CC2)C(=O)/C=C/C3=CC=C(C=C3)Br

NIBR189

CAS : 1599432-08-2

NIBR189

Formule : C₂₁H₂₁BrN₂O₃

Degré de pureté : ≥95%

Masse moléculaire : 429.31

Ref: 54-BUP03042

(E)-3-(4-Bromophenyl)-1-(4-(4-Methoxybenzoyl)Piperazin-1-Yl)Propan-2-En-1-One

CAS : 1599432-08-2

(E)-3-(4-Bromophenyl)-1-(4-(4-Methoxybenzoyl)Piperazin-1-Yl)Propan-2-En-1-One

Formule : C₂₁H₂₁BrN₂O₃

Degré de pureté : 0.98

Masse moléculaire : 429.31

Ref: 54-OR1022975

(2E)-3-(4-Bromophenyl)-1-[4-(4-methoxybenzoyl)-1-piperazinyl]-2-propen-1-one

CAS : 1599432-08-2

Formule : C₂₁H₂₁BrN₂O₃

Degré de pureté : 99%

Couleur et forme : Solid

Masse moléculaire : 429.3070

Ref: IN-DA00ABKZ

NIBR189

CAS : 1599432-08-2

NIBR189 is a potent and selective antagonist of EBI2 (GPR183) receptor (IC50 of 11 and 15 nM for human and mouse EBI2 receptors, respectively)

Formule : C₂₁H₂₁BrN₂O₃

Degré de pureté : 97%

Couleur et forme : White Solid

Masse moléculaire : 429.307

Ref: TM-T7156

(2E)-3-(4-Bromophenyl)-1-[4-(4-methoxybenzoyl)-1-piperazinyl]-2-propen-1-one

Produit contrôlé

CAS : 1599432-08-2

Applications (2E)-3-(4-Bromophenyl)-1-[4-(4-methoxybenzoyl)-1-piperazinyl]-2-propen-1-one recently known as NIBR 189, is a selective Epstein-barr virus-induced gene 2 (EBI-2) receptor antagonist, resulting in a modulation of immune responses related to auto-immune diseases.
References Gessier, F. et al.: J. Med. Chem., 57, 3358 (2014);

Formule : C₂₁H₂₁BrN₂O₃

Couleur et forme : Neat

Masse moléculaire : 429.31

Ref: TR-B688215

NIBR189

CAS : 1599432-08-2

NIBR189 is a highly potent antiviral compound with a wide range of applications. It is a perfluorinated alkaloid that exhibits strong antiviral activity against various viruses. NIBR189 has been extensively studied for its ability to inhibit viral replication and has shown promising results in preclinical trials.

Formule : C₂₁H₂₁BrN₂O₃

Degré de pureté : Min. 95%

Masse moléculaire : 429.31 g/mol

Ref: 3D-ZNC43208